Evvy, a NYC-based provider of a precision medicine platform for women’s health, raised $40M in Series B funding. The oversubscribed round was led by Catalio Capital Management with participation from Rethink Impact, Muse Capital, Alumni Ventures, LabCorp Venture Fund, General Catalyst, Left Lane Capital, BBG Ventures, Amboy Street Ventures, Ingeborg, Foreground Capital, and Flywheel Ventures....See more